Systemic immune-inflammation index predicts new onset atrial fibrillation after ST elevation myocardial infarction


Bağcı A., Aksoy F.

BIOMARKERS IN MEDICINE, vol.15, pp.731-739, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15
  • Publication Date: 2021
  • Doi Number: 10.2217/bmm-2020-0838
  • Journal Name: BIOMARKERS IN MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE
  • Page Numbers: pp.731-739
  • Keywords: atrial fibrillation, ST segment elevation myocardial infarction, systemic immune-inflammation index, ACUTE CORONARY SYNDROMES, SEGMENT ELEVATION, EUROPEAN-SOCIETY, ASSOCIATION, GUIDELINES, MANAGEMENT, RATIO, ESC
  • Süleyman Demirel University Affiliated: Yes

Abstract

Aim: To investigate the predictive capacity of a systemic immune-inflammation index (SII) in detecting new onset atrial fibrillation (NOAF) following ST segment elevation myocardial infarction (STEMI). Patients & methods: A total of 402 STEMI patients were enrolled in the study. The patients were divided into two groups according to NOAF development. Results: A cut-off point of 1,228,000 for SII was identified with 60% sensitivity and 78.1% specificity to predict NOAF following STEMI. According to pairwise analysis of receiver operating characteristic curve analysis, the predictive power of SII in detecting NOAF following STEMI was similar to high-sensitive C-reactive protein, and better than neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio. Conclusion: SII can be used as one of the independent predictors of NOAF following STEMI.